# 바이오스페이스 일일 뉴스 리포트 - 2026년 02월 05일


## 주요 헤드라인

1. **Lilly Eyes Pipeline in a Product as GLP-1s Move Into I&I (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-eyes-pipeline-in-a-product-as-glp-1s-move-into-i-i>

2. **Lilly Eyes Pipeline in a Product as GLP-1s Move Into I&I (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-eyes-pipeline-in-a-product-as-glp-1s-move-into-i-i>

3. **AbbVie’s I&I Portfolio Sells $30 Billion but Execs Again Underline Other Areas (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/abbvies-i-i-portfolio-sells-30-billion-but-execs-again-underline-other-areas>

4. **Novo Goes ‘All In’ on Wegovy Pill but Analysts Worry It’s Not Enough (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-goes-all-in-on-wegovy-pill-but-analysts-worry-its-not-enough>

5. **Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/amgen-wants-maritide-to-change-obesity-paradigm-with-longer-dosing-periods>

6. **Pfizer’s Early Metsera Data Leaves Analysts Wanting More (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizers-early-metsera-data-leaves-analysts-wanting-more>

7. **Pfizer’s Early Metsera Data Leaves Analysts Wanting More (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizers-early-metsera-data-leaves-analysts-wanting-more>


---
*2026년 02월 05일 바이오스페이스 뉴스 피드에서 생성된 리포트*